Rich A. Klinghoffer

Statistics

Publications

Citations

315

H-Index

Active since

2010

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Rich A. Klinghoffer is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in oncogenic signaling pathways, cancer biomarkers, and oncology.

Publications per year

2010–2010

Publications

Pathway-Based Identification of Biomarkers for Targeted Therapeutics: Personalized Oncology with PI3K Pathway Inhibitors

Jannik N. Andersen, Sriram Sathyanarayanan, Alessandra Di Bacco et al. · Science Translational Medicine · 2010 · 162 citations

Medicine, Oncology, Pharmacology +16

A gene expression signature of RAS pathway dependence predicts response to PI3K and RAS pathway inhibitors and expands the population of RAS pathway activated tumors

Andrey Loboda, Michael Nebozhyn, Rich A. Klinghoffer et al. · BMC Medical Genomics · 2010 · 153 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

1–2 of 2